Rejuveron
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- Undisclosed
Investors
- 3
About Rejuveron
Based in Switzerland, and founded in 2019, Rejuveron Life Sciences AG is a clinical-stage biotechnology company providing aging therapies. The company was co-founded by Christian Angermayer, Matthias Steger, Prof. Manuel Serrano, and Timothy Cash. As of 2023, the company is headed by its CEO Aksana Labokha. The company offers novel therapies to tackle diseases of aging. It helps people to age better and live longer. The firm operates its state-of-the-art laboratory facilities in the Schlieren Bio-Technopark.
Who invested in Rejuveron
3 investors across 1 round
See all investors in Rejuveron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 11, 2023
Amount
Undisclosed
Investors
Questions about Rejuveron
Who invested in Rejuveron?
Rejuveron has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rejuveron raised?
Rejuveron has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rejuveron last raise money?
Rejuveron's most recent round on record is a Series B, in Sep 2023.
What does Rejuveron do?
Based in Switzerland, and founded in 2019, Rejuveron Life Sciences AG is a clinical-stage biotechnology company providing aging therapies.
Where is Rejuveron headquartered?
Rejuveron is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Rejuveron?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Rejuveron's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rejuveron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.